Antiretrovirals Flashcards

1
Q

How is Zidovudine administered?

A

Oral

Short acting; given 5X per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the MOA for NRTIs?

A

Nucleoside analogue

Inserts itself into growing chain and inhibits viral reverse transcriptase leading to DNA termination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is significant about the penetration of Zidovudine?

A

Good CNS penetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the uses for Zidovudine?

A

Maintain CD4 count; lessen opportunistic infections

DOC:
HIV in Pregnancy (+ Lamivudine)
AIDS dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are toxicities of Zidovudine?

A
  • Lactic acidosis or hepatoxicity
  • Myelosuppresion: neutropenia, anemia (caution when bone marrow compromised or using ganciclovir, ribavirin)
  • HA, nausea, vomiting, insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the uses of Tenofovir and Emtricitabine?

A

DOC:

HIV (given together)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the toxicities of Tenofovir and Emtricitabine?

A
  • Flatulence

- Lactic acidosis or hepatoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drug should you not use with Tenofovir and Emtricitabine?

A

Do not use with Lamivudine as similar mechanism and resistance profiles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the uses of Lamivudine?

A

DOC:

  • Co-infection of HIV and Hep B
  • HIV in pregnancy (+ Zidovudine)

Monotherapy in HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the toxicities of Lamivudine?

A
  • Lactic acidosis or hepatoxicity

- HA, fatigue, insomnia, GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drugs must you combine with Abacavir?

A

Lamivudine or Zidovudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are toxicities of Abacavir?

A
  • Serious hypersensitivity (screen for HLA-B-5701 as if positive for this allele, has higher chance for SJS)
  • Lactic acidosis or hepatoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are special considerations for Abacavir?

A

Screen for HLA-B-5701 as if positive for this allele, has higher chance for SJS

If hypersensitivity occurs, stop drug and do not restart it as it could be fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA for NNRTIs?

A

Bind directly to inhibit viral reverse transcriptase and prevent conversion of RNA to DNA (no phosphorylation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the uses for Efavirenz?

A

DOC:

Initial HIV treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are toxicities of Efavirenz?

A
  • Drug interactions – induces CYP3A4
  • Decreases effectiveness of oral birth control and methadone
  • Teratogenic!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are contraindications to Efavirenz?

A

Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the uses for Rilpivirine?

A

DOC:

Initial HIV therapy in pregnant patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are contraindications for Rilpivirine?

A

Patients with hepatitis co-infection as may increase liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the MOA of all protease inhibitors?

A

Inhibit proteases which inhibits the production of smaller proteins and ultimately decreases viral loads as they cannot replicate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the drug reactions associated with protease inhibitors?

A

Protease inhibitors are metabolized by CYP3A4 and have interactions with drugs that induce CYP3A4 such as Rifampin and Rifabutin

22
Q

What protease inhibitor is given with other protease inhibitors and why?

A

Ritonavir is often given in combination because it is a potent inhibitor of CYP3A4 which increases PI levels for lower dose/less frequent dosing

23
Q

What should you not use with protease inhibitors and why?

A

Should not use St. John’s Wort as it increases the metabolism of protease inhibitors

Should not combine with statins as protease inhibitors already increase serum cholesterol

24
Q

What are common toxicities associated with all protease inhibitors?

A
  • Altered body fat distribution
  • Insulin resistance
  • Increase in serum cholesterol (do not combine with statins)
  • Spontaneous bleeding
25
Q

What are the uses of Ritonavir?

A

Boosts bioavailability of other protease inhibitors

26
Q

What are toxicities of Ritonavir?

A
  • Inhibits CYP3A4 – combine with other protease inhibitors to increase their bioavailability
  • Prolonged QT (if combined with saquinavir)
  • Contains ethanol (do not give with metronidazole or cephalosporins)
27
Q

What are the toxicities of Darunavir?

A
  • Rash, nausea, diarrhea, HA, bad dreams

- Contains sulfonamide moiety

28
Q

What are contraindications for Darunavir?

A

Patients with sulfa allergy as drug contains sulfa moiety

29
Q

What are the toxicities of Atazenavir?

A
  • Less effect on body fat distribution
  • May increase bilirubin due to inhibition of UGT
  • Diarrhea, rash, nausea, hypoglycemia
30
Q

What are contraindications to Atazenavir?

A

Infants (inhibits UGT and can increase bilirubin)

31
Q

What are contradindications of Saquinavir?

A
  • QT prolongation (DO NOT combine with ritonavir)

- GI side effects

32
Q

What are toxicities of Lopinavir/Ritonavir?

A
  • Diarrhea, nausea

- Liver enzyme elevation if pre-existing hepatic disease

33
Q

What are toxicities of Indinavir?

A
  • Nephrolithiasis
  • Hyperbilirubinemia due to urinary crystallization
  • Need aggressive hydration
34
Q

What other protease inhibitor should not be given with Ritonavir and why?

A

Do not combine Saquinavir with Ritonavir as they will cause QT prolongation

35
Q

What is the MOA for Enfuvirtide (Fuzeon)?

A

Fusion inhibitor

Bind to gp41 subunit of viral envelope glycoprotein; prevents conformational change required for membrane fusion and viral entry into target cells

36
Q

What are uses of Enfuvirtide (Fuzeon)?

A

Advanced disease who are treatment-experienced

Combine with other antiretrovirals

37
Q

What are toxicities of Enfuvirtide (Fuzeon)?

A

Increased likelihood of bacterial pneumonia

38
Q

What is the MOA for Maraviroc?

A

Fusion inhibitor

Inhibits fusion of virus by binding to CCR5 receptor of CD4 T-cell – one of two chemokine receptors needed for HIV entry into cell

39
Q

What are uses of Maraviroc?

A

ONLY in those with CCR5-tropic HIV infection in which other treatment has not been effective

40
Q

What is the MOA for Dolutegravir?

A

Integrase inhibitor

Blocks integrase enzyme needed for replication

41
Q

What are uses for Dolutegravir?

A

Used in treatment resistant patients where other drugs are no longer working

42
Q

What is the NRTI DOC for HIV?

A

Tenofovir + Emtricitabine

43
Q

What is the NRTI DOC for pregnant HIV patients?

A

Zidovudine + Lamivudine

44
Q

What is the NRTI DOC for co-infection of HIV and Hepatitis B?

A

Lamivudine

45
Q

What is the NNRTI DOC for HIV?

A

Efavirenz

46
Q

What is the NNRTI DOC for pregnant HIV patients?

A

Rilpivirine

47
Q

What is the Protease Inhibitor DOC for HIV?

A

Darunavir

48
Q

What is the Protease Inhibitor 2nd DOC for HIV?

A

Atazenavir

49
Q

What is the Integrase Inhibitor DOC for HIV?

A

Dolutegravir

50
Q

What antiretroviral regiment is given for a treatment-naive patient?

What does this consist of?

A

HAART

Two NRTIs
A third drug from one of three drug classes: 
- NNRTI
- Protease Inhibitor (PI)
- Integrase Inhibitor
51
Q

What is the Protease Inhibitor 2nd DOC for HIV?

A

Atazenavir